Location History:
- Armonk, NY (US) (2020 - 2022)
- Chappaqua, NY (US) (2018 - 2023)
Company Filing History:
Years Active: 2018-2025
Title: Judith Altarejos: Innovator in Leptin Receptor Therapeutics
Introduction
Judith Altarejos is a prominent inventor based in Chappaqua, NY, known for her significant contributions to the field of metabolic dysfunction treatment. With a total of nine patents to her name, she has made remarkable strides in developing therapeutic methods that target leptin receptor signaling.
Latest Patents
Among her latest patents, one focuses on methods of treatment using a leptin receptor agonist antibody. This invention provides therapeutic methods for conditions related to metabolic dysfunction, such as lipodystrophy, obesity, and insulin resistance. Another notable patent involves antigen-binding proteins that activate the leptin receptor. This invention includes antibodies and fragments that enhance LEPR signaling, offering potential treatments for diseases associated with leptin deficiency or resistance.
Career Highlights
Judith Altarejos is currently associated with Regeneron Pharmaceuticals, Inc., where she continues to innovate in the field of biotechnology. Her work has been instrumental in advancing therapeutic options for patients suffering from metabolic disorders.
Collaborations
Some of her notable coworkers include Jesper Gromada and Panayiotis Stevis, who contribute to her research and development efforts.
Conclusion
Judith Altarejos exemplifies the spirit of innovation in the medical field, particularly in the treatment of metabolic disorders through her groundbreaking patents and collaborative efforts. Her work continues to pave the way for new therapeutic approaches that can significantly impact patient care.